Natco Pharma Buyback 2023 FAQ's

The Natco Pharma Buyback 2023 price is set at Rs 700 Per Share. The Natco Pharma Buyback 2023 opens on March 21, 2023 and closes on May 12, 2023.

There is no concept of Tender form in case of an open market offer through the Stock exchange. Any equity shareholder holding the Equity shares of Natco Pharma Buyback 2023 can participate in the buyback offer through their stockbroker.

The Public Announcement for Natco Pharma Buyback 2023 can be download here.

Any equity shareholder holding the shares in Demat form can participate in the buyback offer through their stockbroker. The physical shareholder can participate only once the shares get converted into a Dematerialized form.

The shareholder needs to inform their broker on the details of the Equity shares they wish to sell. The broker will place a sell order whenever the company places a buy order for the buyback. The trade would get executed at the offer price or lesser only when the price offered by the shareholder matches with the buy order placed by the company.

Necessity of the Issue:

The Buyback is being undertaken for the following reasons:

1. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares
2. The Buyback may help in improving return on equity, by the reduction in the equity base.
3. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.

The Natco Pharma Buyback 2023 offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one’s need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.